The share issuance is a pre-announced administrative step with no new capital raise. Monitor for any drawdowns on the $50M revolving credit facility, which would signal cash burn and potential further dilution.
Price Chart
Executive Summary
TuHURA Biosciences filed an 8-K reporting that stockholders approved the issuance of 1,878,287 common shares to Parkview Holdings One LLC as loan fee shares under a $50M revolving credit facility. The share issuance, which was contingent on stockholder approval, is now authorized and will be issued to an accredited investor in a private placement. This is a routine administrative step completing a previously disclosed financing arrangement, with no new capital raised or change in terms.
Key Financial Metrics
Key Facts
- Stockholders approved the issuance of 1,878,287 shares to Parkview Holdings One LLC as loan fee shares under a $50M revolving credit facility.
- The shares will be issued in a private placement to an accredited investor under Section 4(a)(2)/Regulation D.
- As of the June 26, 2026 record date, 63,682,528 shares were outstanding; the new shares represent approximately 2.95% dilution.
- The 2026 Annual Meeting was held on August 18, 2026, with all director nominees elected and auditor ratification approved.
Financial Impact
Issuance of 1,878,287 shares (~2.95% dilution) as compensation for a previously established $50M credit facility; no new cash proceeds.
Risk Factors
- Potential future drawdowns on the $50M credit facility could increase leverage and dilution.
- The company is a clinical-stage biotech with no disclosed revenue; cash runway and pipeline progress are key risks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (HURA) — Batch item 1 | 0001193125-26-357087 |
| Document: 0001193125-26-357087-index-headers.html | 0001193125-26-357087 |
| Document: 0001193125-26-357087-index.html | 0001193125-26-357087 |
| Document: 0001193125-26-357087.txt | 0001193125-26-357087 |
| 8-K Filing (HURA) — Batch item 5 | 0001193125-26-357087 |
| Document: 0001193125-26-357087-index-headers.html | 0001193125-26-357087 |
| Document: 0001193125-26-357087-index.html | 0001193125-26-357087 |
| Document: 0001193125-26-357087.txt | 0001193125-26-357087 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | 8-K | $1.78 | awaiting T+60 | — | $2.03 (+14.04%) |
Sep 24, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 17, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 16, 2026 5w ago | 8-K | $2.09 | awaiting T+60 | — | $2.03 (−2.87%) |
Sep 4, 2026 7w ago | 8-K | $2.12 | awaiting T+60 | — | $2.03 (−4.25%) |
Aug 19, 2026 9w ago | 8-K | $2.22 | awaiting T+60 | — | $2.03 (−8.56%) |
Aug 14, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 14, 2026 10w ago | Press Release | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 13, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Jul 29, 2026 12w ago | 8-K | $2.17 $2.18 | ▲ +0.46% | ▼ −2.00% | $2.03 (−6.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers